文献速递艾滋病与性传播感染

中年HIV感染者慢性肾病患病率更高且进展更快:AGEhIV队列研究

Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls.
PubMed 文献 · J Infect Dis · 2017-01-01

AGEhIV队列研究比较596例HIV感染者和544例未感染者,发现HIV感染独立关联肾功能受损(aOR=2.1)、白蛋白尿(aOR=5.8)和近端肾小管功能障碍(aOR=7.0)。纵向分析中,持续使用未修改cART的HIV感染者eGFR下降更快且白蛋白尿恶化风险更高。

要点

  • HIV感染者肾功能受损、白蛋白尿和近端肾小管功能障碍风险显著增高。
  • 持续cART的HIV感染者eGFR年下降更快,白蛋白尿恶化风险增加。
  • 中年HIV感染者应加强肾脏功能监测,包括白蛋白尿和肾小管功能评估。

核心结论

  • 中年HIV感染者肾功能受损、白蛋白尿和近端肾小管功能障碍患病率更高。
  • 持续使用未修改cART的HIV感染者eGFR下降更快且白蛋白尿恶化风险更高。

研究设计与样本

  • AGEhIV队列研究,比较596例HIV感染者和544例HIV未感染者的肾脏指标。
  • 纵向分析纳入377例HIV感染者和479例未感染者,中位随访分别为3.9年和4.1年。

主要发现

  • HIV感染独立关联肾功能受损(aOR=2.1;95%CI=1.0-4.4)。
  • HIV感染独立关联白蛋白尿(aOR=5.8;95%CI=3.7-9.0)。
  • HIV感染独立关联近端肾小管功能障碍(aOR=7.0;95%CI=4.9-10.2)。
  • 持续未修改cART的HIV感染者eGFR下降更显著(-0.56;95%CI=-0.87至-0.24 mL/min/1.73m2/年)。
  • 持续未修改cART的HIV感染者白蛋白尿恶化风险更高(aOR=2.3;95%CI=1.3-4.0)。

关键数值与推荐

  • 肾功能受损定义为eGFR<60 mL/min/1.73m2。
  • 白蛋白尿定义为白蛋白/肌酐比值≥3 mg/mmol。
  • 近端肾小管功能障碍定义为视黄醇结合蛋白/肌酐比值>2.93μg/mmol和/或血浆磷酸盐<0.8 mmol/L时分数磷酸盐排泄>20%。
  • 白蛋白尿恶化定义为白蛋白尿年增加≥10%且白蛋白尿类别改变。

临床怎么用

  • 对中年HIV感染者应常规筛查肾功能、白蛋白尿及近端肾小管功能。
  • 使用cART(尤其含富马酸替诺福韦二吡呋酯)者需监测eGFR下降和白蛋白尿进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human immunodeficiency virus (HIV)-infected individuals are at increased risk of chronic kidney disease (CKD). Human immunodeficiency virus infection, traditional CKD risk factors, and combination antiretroviral therapy (cART) may all contribute. METHODS: We compared prevalence of renal impairment (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73m2), albuminuria (albumin/creatinine ratio ≥3 mg/mmol), and proximal renal tubular dysfunction (retinol-binding protein/creatinine ratio >2.93μg/mmol and/or fractional phosphate excretion >20% with plasma phosphate <0.8 mmol/L) in 596 HIV-infected and 544 HIV-uninfected AGEhIV Cohort Study participants. We also assessed whether being HIV-infected on cART, with follow-up censored when cART regimen was modified, was associated with greater eGFR decline or worsening albuminuria (increase ≥10%/year with change in albuminuria category). RESULTS: Human immunodeficiency virus infection was independently associated with renal impairment (adjusted odds ratio [aOR] = 2.1; 95% confidence interval [CI] = 1.0-4.4), albuminuria (aOR = 5.8; 95% CI = 3.7-9.0), and proximal renal tubular dysfunction (aOR = 7.0; 95% CI = 4.9-10.2]). Among 377 HIV-infected and 479 HIV-uninfected individuals (median follow-up = 3.9/4.1 years, respectively) included in longitudinal analyses, being HIV-infected and remaining on unmodified cART was independently associated with greater eGFR decline (-0.56; 95% CI = -0.87 to -0.24 mL/min/1.73m2/year) and worsening albuminuria (aOR = 2.3; 95% CI = 1.3-4.0). CONCLUSIONS: In these middle-aged individuals, HIV infection was independently associated with renal impairment, albuminuria, and proximal renal tubular dysfunction. Human immunodeficiency virus-infected individuals on cART (predominantly containing tenofovir disoproxil fumarate) were also more likely to experience eGFR decline and worsening albuminuria compared with HIV-uninfected individuals.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Kooij KW, Vogt L, Wit FWNM, et al. Higher Prevalence and Faster Progression of Chronic Kidney Disease in Human Immunodeficiency Virus-Infected Middle-Aged Individuals Compared With Human Immunodeficiency Virus-Uninfected Controls. J Infect Dis. 2017. PMID: 28934420. doi:10.1093/infdis/jix202

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。